Cytomos

The corporate group at Burges Salmon has advised Cytomos, an Edinburgh-based life science company, on a £4m funding package to support the development of cell analysis solutions for the biopharma industry and fast-track novel therapies to market. The investment round was led by existing invest

Edinburgh-based life science firm Cytomos has successfully raised £4 million in a recent investment round for the development and market-testing of its Cytomos Dielectric Spectroscopy (CDS) technology. Archangels led this funding initiative with participation from notable investors such as Old

Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £1.6 million funding to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS). The fundraising round by